Result card

  • SAF4: Do IVIG interfere with or are affected by other treatments used in patients with Mild Cognitive Impairment or in patients with Alzheimer’s disease?
English

Do IVIG interfere with or are affected by other treatments used in patients with Mild Cognitive Impairment or in patients with Alzheimer’s disease?

Authors: Luca Vignatelli, Luciana Ballini, Susanna Maltoni, Jelena Barbaric, Mirjana Huic, Pernilla Östlund

Internal reviewers: Gerardo Atienza, Lavinia Panait

The same methodology was used as described in section for the whole domain.

MCI

No trials on patients with MCI were retrieved.

AD

No trials reporting data regarding the interaction between IVIG and other drugs were retrieved.

Important
Completely
Vignatelli L et al. Result Card SAF4 In: Vignatelli L et al. Safety In: Jefferson T, Cerbo M, Vicari N [eds.]. Use of Intravenous immunoglobulins for Alzeheimer’s disease including Mild Cognitive Impairment [Core HTA], Agenas - Agenzia nazionale per i servizi sanitari regionali ; 2015. [cited 30 October 2020]. Available from: http://corehta.info/ViewCover.aspx?id=267

References